CHRONOS-4: Phase 3 Study of Copanlisib Plus Rituximab-Based Immunochemotherapy in Relapsed Indolent B-cell Lymphoma
Pier Luigi Zinzani,Huaqing Wang,Jifeng Feng,Tae Min Kim,Rong Tao,Huilai Zhang,Laura Fogliatto,Clara Maluquer Artigal,Muhit Ozcan,Eduardo Yanez,Won Seog Kim, Dmitry Kirtbaya,Iryna Kriachok, Felipe Maciel,Hongwei Xue,Krimo Bouabdallah,Charles Phelps,Shalini Chaturvedi,Anke Weispfenning,Peter N. Morcos, Fatuma Odongo,Viktoriya Buvaylo,Barrett H. Childs,Martin Dreyling,Matthew Matasar,Paola Ghione Blood Advances（2024）
关键词
Non-Hodgkin lymphoma,Phase III,PI3K inhibitor
AI 理解论文
溯源树
样例
